GlassScriptPhysician profile
Yifang Wang
NPI 1386165355
$1,691.37
in general payments reported to CMS, 2019-2025
18 companies · $51.97 in 2025
The $51.97 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2021: $238 · 2022: $593 · 2023: $338 · 2024: $262 · 2025: $51.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $305.00 | 2022 | |
| Integra Lifesciences Corporation | $237.73 | 2021 | |
| Ethicon US, LLC | $229.74 | 2024 | Dermabond Prineo, Echelon; Endopath, Echelon Endopath |
| Abbvie INC. | $179.89 | 2022-2023 | Avycaz, Mavyret, Teflaro |
| Access Pro Medical, LLC | $173.40 | 2023 | Matriderm |
| Davol INC. | $131.21 | 2019 | |
| Astellas Pharma US INC | $64.40 | 2022 | |
| Depuy Synthes Sales INC. | $51.51 | 2023-2025 | Matrixrib |
| Tela Bio, INC. | $48.35 | 2019 | |
| Alexion Pharmaceuticals, INC. | $48.13 | 2022 | |
| Eisai INC. | $45.31 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $39.62 | 2022-2023 | Zerbaxa, Dificid |
| Becton, Dickinson and Company | $32.38 | 2024 | Phasix Mesh |
| Intuitive Surgical, INC. | $28.14 | 2019 | |
| Kerecis Limited | $22.01 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $21.87 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.11 | 2022 | |
| Smith+Nephew, INC. | $14.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yifang Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.